IDH receives approval from the FRA for its dual listing on the Egyptian Exchange

Trading expected to commence on May 20

  
IDH receives approval from the FRA for its dual listing on the Egyptian Exchange

The listing of the EGP-denominated ordinary shares will position IDH as the sole dual-listed Egyptian company on both the Egyptian Exchange and the London Stock Exchange 

Cairo: Further to its announcements on 22 March 2021 and 5 May 2021, Integrated Diagnostics Holdings ("IDH," "the Company" or "the Group”, IDHC on the London Stock Exchange ("the LSE")), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, announces that it has received approval from the Egyptian Financial Regulatory Authority ("the FRA") for the dual listing of the Company's ordinary shares on the Egyptian Exchange's ("the EGX") main market under the EGX ticker code IDHC.CA and ISIN code EGS99021C015.

Following the EGX's approval received on 5 May 2021, FRA approval allows the Company to proceed trading on the EGX, which is expected to begin on 20 May 2021.

The technical listing is without any concurrent offering of new shares by the Company, the first of its kind on the EGX, and meets the regulatory requirements of the EGX listing and delisting rules, including a 5% minimum free float (equivalent to 30,000,000 shares) on the exchange. The EGX-listed shares will be denominated and traded in Egyptian Pounds ("EGP"), and will be complementary to the Company's USD-denominated shares that are currently listed and traded on the LSE. 

Commenting on the EGX's approval, CEO Dr. Hend El Sherbini said: "We are delighted to have received the final regulatory approval and the FRA's signoff on our dual listing on the EGX. This follows IDH's successful roadshow that garnered strong interest from local investors looking to capitalize on our Group's growth story. The listing will help improve liquidity and increases IDH's visibility in our home market of Egypt."

"At the time of our IPO in 2015, IDH was the first Egyptian healthcare company to be listed on the London Stock Exchange. Today, with the approval for our technical listing on the EGX, we are yet again at the forefront with IDH being the sole dual-listed Egyptian company on the LSE and EGX. We are also proud to have pioneered the technical listing model, the first of its kind on the EGX and one that is bound to encourage more firms to proceed with listings and grow the EGX's attractiveness," El Sherbini added.

The dual listing boasts a fungible structure between the LSE and the EGX whereby shares are easily transferred between the two exchanges through a set share transfer mechanism. Full details of the mechanism will be made available at IDH's website prior to the commencement of trading on the EGX.

EFG Hermes and Renaissance Capital are advising the Company in connection with the dual listing. Clifford Chance (as to English and US law), Ogier (as to Jersey law) and White & Case (as to Egyptian law) are acting as legal counsel to the Company.

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases